BPC-157 (Pentadecapeptide) Posologie 200 - 400 mcg par jour, sous forme d'injections intramusculaires
While research shows some benefits (for example improved sleep efficiency, reduced sleep latency) in controlled settings, there are still questions around long-term safety, especially in healthy subjects or non-clinical contexts
B12 therapy requires the same kind of regular check-ins to stay effective
Overexpression of glutathione-S-transferase, MGSTII, confers resistance to busulfan [PMID: 15779864] Laboratory literature summary: Overexpression of glutathione-S-transferase, MGSTII, confers resistance to busulfan and melphalan
It is weekly, not monthly to quarterly, dosing
Vascular injury and thrombotic disorders show interesting preclinical findings with BPC-157 preventing pathological thrombus formation while maintaining physiological hemostasis